{
  "paper": {
    "paper_id": "30617256_table1",
    "pmcid": "",
    "pmid": "30617256",
    "pdf": "/Users/sherryhuang/advp_curator/paper/nihms-1031924.pdf",
    "table_input": "/Users/sherryhuang/advp_curator/table_from_link/30617256_table1.xlsx",
    "full_text_source": "pdfplumber",
    "id_evidence": "PMID inferred from source filename -> 30617256"
  },
  "table_source_errors": [],
  "global_field_audit": [
    {
      "field": "Stage",
      "value": "Meta-analysis",
      "confidence": 0.8,
      "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
      "rule": "found meta-analysis cues",
      "needs_review": false
    },
    {
      "field": "Analyses type",
      "value": "Imaging",
      "confidence": 0.7,
      "evidence": "Author Manuscript Author Manuscript Author Manuscript Author Manuscript Jansen et al. Page 18 Hospital, Trondheim University Hospital, Trondheim, Norway. 22.Neuroradiology Section, Department of Radiology and Biomedical Imaging, University of California, San Francisco, USA. 23.Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. 24.Vanderbilt Memory & Alzheimer’s Center, Department of Neurology, Vanderbilt University Medical",
      "rule": "matched association keywords -> Imaging",
      "needs_review": true
    },
    {
      "field": "Model type",
      "value": "logistic regression (with covariates)",
      "confidence": 0.75,
      "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phenotypes (cases versus controls for ADSP and PGC-ALZ cohorts), and linear regression for phenotypes analysed as continuous outcomes (proxy phenotype constructed as the number of parents with",
      "rule": "model family + covariate cues",
      "needs_review": true
    },
    {
      "field": "Imputation_simple2",
      "value": "1000G",
      "confidence": 0.85,
      "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 of the 7 novel loci tested for replication, we observed the same direction of effect in the deCODE cohort. Furthermore, 4 loci (CLNK, ADAM10, APH1B, AC074212.3) showed nominally signific",
      "rule": "panel keyword detection (TOPMed/HRC/1000G)",
      "needs_review": false
    },
    {
      "field": "Population",
      "value": "European ancestry",
      "confidence": 0.75,
      "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing quality control (Figure 1, Supplementary Table 1). The ADSP subset encompassed whole exome sequencing data from 4,343 cases and 3,163 controls, while the remainin",
      "rule": "section-aware population keyword",
      "needs_review": true
    },
    {
      "field": "Sample size",
      "value": "72500",
      "confidence": 0.7,
      "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing quality control (Figure 1, Supplementary Table 1). The ADSP subset encompassed whole exome sequencing data fr",
      "rule": "section-aware sample size extraction",
      "needs_review": true
    }
  ],
  "record_field_audit": [
    {
      "RecordID": "30617256_table1_R00001",
      "fields": [
        {
          "field": "Name",
          "value": "rs4575098",
          "confidence": 0.9,
          "evidence": "Row text: 1 | 1 | ADAMTS4 | rs4575098 | 0.000157 | rs4575098 | 6.88e-08 | rs4575098 | 161155392 | A | G | 0.24 | 6.36 | 2.05e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 0.000157,
          "confidence": 0.7,
          "evidence": "Row text: 1 | 1 | ADAMTS4 | rs4575098 | 0.000157 | rs4575098 | 6.88e-08 | rs4575098 | 161155392 | A | G | 0.24 | 6.36 | 2.05e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 1 | 1 | ADAMTS4 | rs4575098 | 0.000157 | rs4575098 | 6.88e-08 | rs4575098 | 161155392 | A | G | 0.24 | 6.36 | 2.05e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 1 | 1 | ADAMTS4 | rs4575098 | 0.000157 | rs4575098 | 6.88e-08 | rs4575098 | 161155392 | A | G | 0.24 | 6.36 | 2.05e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00002",
      "fields": [
        {
          "field": "Name",
          "value": "rs4575098",
          "confidence": 0.9,
          "evidence": "Row text: 1 | 1 | ADAMTS4 | rs4575098 | 0.000157 | rs4575098 | 6.88e-08 | rs4575098 | 161155392 | A | G | 0.24 | 6.36 | 2.05e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 6.88e-08,
          "confidence": 0.7,
          "evidence": "Row text: 1 | 1 | ADAMTS4 | rs4575098 | 0.000157 | rs4575098 | 6.88e-08 | rs4575098 | 161155392 | A | G | 0.24 | 6.36 | 2.05e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 1 | 1 | ADAMTS4 | rs4575098 | 0.000157 | rs4575098 | 6.88e-08 | rs4575098 | 161155392 | A | G | 0.24 | 6.36 | 2.05e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 1 | 1 | ADAMTS4 | rs4575098 | 0.000157 | rs4575098 | 6.88e-08 | rs4575098 | 161155392 | A | G | 0.24 | 6.36 | 2.05e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00003",
      "fields": [
        {
          "field": "Name",
          "value": "rs4575098",
          "confidence": 0.9,
          "evidence": "Row text: 1 | 1 | ADAMTS4 | rs4575098 | 0.000157 | rs4575098 | 6.88e-08 | rs4575098 | 161155392 | A | G | 0.24 | 6.36 | 2.05e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.05e-10,
          "confidence": 0.7,
          "evidence": "Row text: 1 | 1 | ADAMTS4 | rs4575098 | 0.000157 | rs4575098 | 6.88e-08 | rs4575098 | 161155392 | A | G | 0.24 | 6.36 | 2.05e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 6.36,
          "confidence": 0.65,
          "evidence": "Row text: 1 | 1 | ADAMTS4 | rs4575098 | 0.000157 | rs4575098 | 6.88e-08 | rs4575098 | 161155392 | A | G | 0.24 | 6.36 | 2.05e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 1 | 1 | ADAMTS4 | rs4575098 | 0.000157 | rs4575098 | 6.88e-08 | rs4575098 | 161155392 | A | G | 0.24 | 6.36 | 2.05e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00004",
      "fields": [
        {
          "field": "Name",
          "value": "rs6656401",
          "confidence": 0.9,
          "evidence": "Row text: 2 | 1 | CR1 | rs6656401 | 1.39e-17 | rs679515 | 8.85e-10 | rs2093760 | 207786828 | A | G | 0.205 | 8.82 | 1.1e-18 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.39e-17,
          "confidence": 0.7,
          "evidence": "Row text: 2 | 1 | CR1 | rs6656401 | 1.39e-17 | rs679515 | 8.85e-10 | rs2093760 | 207786828 | A | G | 0.205 | 8.82 | 1.1e-18 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 2 | 1 | CR1 | rs6656401 | 1.39e-17 | rs679515 | 8.85e-10 | rs2093760 | 207786828 | A | G | 0.205 | 8.82 | 1.1e-18 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 2 | 1 | CR1 | rs6656401 | 1.39e-17 | rs679515 | 8.85e-10 | rs2093760 | 207786828 | A | G | 0.205 | 8.82 | 1.1e-18 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00005",
      "fields": [
        {
          "field": "Name",
          "value": "rs679515",
          "confidence": 0.9,
          "evidence": "Row text: 2 | 1 | CR1 | rs6656401 | 1.39e-17 | rs679515 | 8.85e-10 | rs2093760 | 207786828 | A | G | 0.205 | 8.82 | 1.1e-18 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 8.85e-10,
          "confidence": 0.7,
          "evidence": "Row text: 2 | 1 | CR1 | rs6656401 | 1.39e-17 | rs679515 | 8.85e-10 | rs2093760 | 207786828 | A | G | 0.205 | 8.82 | 1.1e-18 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 2 | 1 | CR1 | rs6656401 | 1.39e-17 | rs679515 | 8.85e-10 | rs2093760 | 207786828 | A | G | 0.205 | 8.82 | 1.1e-18 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 2 | 1 | CR1 | rs6656401 | 1.39e-17 | rs679515 | 8.85e-10 | rs2093760 | 207786828 | A | G | 0.205 | 8.82 | 1.1e-18 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00006",
      "fields": [
        {
          "field": "Name",
          "value": "rs2093760",
          "confidence": 0.9,
          "evidence": "Row text: 2 | 1 | CR1 | rs6656401 | 1.39e-17 | rs679515 | 8.85e-10 | rs2093760 | 207786828 | A | G | 0.205 | 8.82 | 1.1e-18 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.1e-18,
          "confidence": 0.7,
          "evidence": "Row text: 2 | 1 | CR1 | rs6656401 | 1.39e-17 | rs679515 | 8.85e-10 | rs2093760 | 207786828 | A | G | 0.205 | 8.82 | 1.1e-18 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 8.82,
          "confidence": 0.65,
          "evidence": "Row text: 2 | 1 | CR1 | rs6656401 | 1.39e-17 | rs679515 | 8.85e-10 | rs2093760 | 207786828 | A | G | 0.205 | 8.82 | 1.1e-18 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 2 | 1 | CR1 | rs6656401 | 1.39e-17 | rs679515 | 8.85e-10 | rs2093760 | 207786828 | A | G | 0.205 | 8.82 | 1.1e-18 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00007",
      "fields": [
        {
          "field": "Name",
          "value": "rs4663105",
          "confidence": 0.9,
          "evidence": "Row text: 3 | 2 | BIN1 | rs4663105 | 3.58e-29 | rs4663105 | 5.460000000000001e-26 | rs4663105 | 127891427 | C | A | 0.415 | 13.94 | 3.38e-44 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 3.58e-29,
          "confidence": 0.7,
          "evidence": "Row text: 3 | 2 | BIN1 | rs4663105 | 3.58e-29 | rs4663105 | 5.460000000000001e-26 | rs4663105 | 127891427 | C | A | 0.415 | 13.94 | 3.38e-44 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 3 | 2 | BIN1 | rs4663105 | 3.58e-29 | rs4663105 | 5.460000000000001e-26 | rs4663105 | 127891427 | C | A | 0.415 | 13.94 | 3.38e-44 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 3 | 2 | BIN1 | rs4663105 | 3.58e-29 | rs4663105 | 5.460000000000001e-26 | rs4663105 | 127891427 | C | A | 0.415 | 13.94 | 3.38e-44 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00008",
      "fields": [
        {
          "field": "Name",
          "value": "rs4663105",
          "confidence": 0.9,
          "evidence": "Row text: 3 | 2 | BIN1 | rs4663105 | 3.58e-29 | rs4663105 | 5.460000000000001e-26 | rs4663105 | 127891427 | C | A | 0.415 | 13.94 | 3.38e-44 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 5.460000000000001e-26,
          "confidence": 0.7,
          "evidence": "Row text: 3 | 2 | BIN1 | rs4663105 | 3.58e-29 | rs4663105 | 5.460000000000001e-26 | rs4663105 | 127891427 | C | A | 0.415 | 13.94 | 3.38e-44 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 3 | 2 | BIN1 | rs4663105 | 3.58e-29 | rs4663105 | 5.460000000000001e-26 | rs4663105 | 127891427 | C | A | 0.415 | 13.94 | 3.38e-44 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 3 | 2 | BIN1 | rs4663105 | 3.58e-29 | rs4663105 | 5.460000000000001e-26 | rs4663105 | 127891427 | C | A | 0.415 | 13.94 | 3.38e-44 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00009",
      "fields": [
        {
          "field": "Name",
          "value": "rs4663105",
          "confidence": 0.9,
          "evidence": "Row text: 3 | 2 | BIN1 | rs4663105 | 3.58e-29 | rs4663105 | 5.460000000000001e-26 | rs4663105 | 127891427 | C | A | 0.415 | 13.94 | 3.38e-44 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 3.38e-44,
          "confidence": 0.7,
          "evidence": "Row text: 3 | 2 | BIN1 | rs4663105 | 3.58e-29 | rs4663105 | 5.460000000000001e-26 | rs4663105 | 127891427 | C | A | 0.415 | 13.94 | 3.38e-44 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 13.94,
          "confidence": 0.65,
          "evidence": "Row text: 3 | 2 | BIN1 | rs4663105 | 3.58e-29 | rs4663105 | 5.460000000000001e-26 | rs4663105 | 127891427 | C | A | 0.415 | 13.94 | 3.38e-44 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 3 | 2 | BIN1 | rs4663105 | 3.58e-29 | rs4663105 | 5.460000000000001e-26 | rs4663105 | 127891427 | C | A | 0.415 | 13.94 | 3.38e-44 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00010",
      "fields": [
        {
          "field": "Name",
          "value": "rs10933431",
          "confidence": 0.9,
          "evidence": "Row text: 4 | 2 | INPPD5 | rs10933431 | 1.67e-06 | rs10933431 | 2.51e-06 | rs10933431 | 233981912 | G | C | 0.235 | −6.13 | 8.92e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.67e-06,
          "confidence": 0.7,
          "evidence": "Row text: 4 | 2 | INPPD5 | rs10933431 | 1.67e-06 | rs10933431 | 2.51e-06 | rs10933431 | 233981912 | G | C | 0.235 | −6.13 | 8.92e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 4 | 2 | INPPD5 | rs10933431 | 1.67e-06 | rs10933431 | 2.51e-06 | rs10933431 | 233981912 | G | C | 0.235 | −6.13 | 8.92e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 4 | 2 | INPPD5 | rs10933431 | 1.67e-06 | rs10933431 | 2.51e-06 | rs10933431 | 233981912 | G | C | 0.235 | −6.13 | 8.92e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00011",
      "fields": [
        {
          "field": "Name",
          "value": "rs10933431",
          "confidence": 0.9,
          "evidence": "Row text: 4 | 2 | INPPD5 | rs10933431 | 1.67e-06 | rs10933431 | 2.51e-06 | rs10933431 | 233981912 | G | C | 0.235 | −6.13 | 8.92e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.51e-06,
          "confidence": 0.7,
          "evidence": "Row text: 4 | 2 | INPPD5 | rs10933431 | 1.67e-06 | rs10933431 | 2.51e-06 | rs10933431 | 233981912 | G | C | 0.235 | −6.13 | 8.92e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 4 | 2 | INPPD5 | rs10933431 | 1.67e-06 | rs10933431 | 2.51e-06 | rs10933431 | 233981912 | G | C | 0.235 | −6.13 | 8.92e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 4 | 2 | INPPD5 | rs10933431 | 1.67e-06 | rs10933431 | 2.51e-06 | rs10933431 | 233981912 | G | C | 0.235 | −6.13 | 8.92e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00012",
      "fields": [
        {
          "field": "Name",
          "value": "rs10933431",
          "confidence": 0.9,
          "evidence": "Row text: 4 | 2 | INPPD5 | rs10933431 | 1.67e-06 | rs10933431 | 2.51e-06 | rs10933431 | 233981912 | G | C | 0.235 | −6.13 | 8.92e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 8.92e-10,
          "confidence": 0.7,
          "evidence": "Row text: 4 | 2 | INPPD5 | rs10933431 | 1.67e-06 | rs10933431 | 2.51e-06 | rs10933431 | 233981912 | G | C | 0.235 | −6.13 | 8.92e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": -6.13,
          "confidence": 0.65,
          "evidence": "Row text: 4 | 2 | INPPD5 | rs10933431 | 1.67e-06 | rs10933431 | 2.51e-06 | rs10933431 | 233981912 | G | C | 0.235 | −6.13 | 8.92e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 4 | 2 | INPPD5 | rs10933431 | 1.67e-06 | rs10933431 | 2.51e-06 | rs10933431 | 233981912 | G | C | 0.235 | −6.13 | 8.92e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00013",
      "fields": [
        {
          "field": "Name",
          "value": "rs184384746",
          "confidence": 0.9,
          "evidence": "Row text: 5 | 3 | HESX1 |  |  | rs184384746 | 1.24e-08 | rs184384746 | 57226150 | T | C | 0.002 | 5.69 | 1.24e-08 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.24e-08,
          "confidence": 0.7,
          "evidence": "Row text: 5 | 3 | HESX1 |  |  | rs184384746 | 1.24e-08 | rs184384746 | 57226150 | T | C | 0.002 | 5.69 | 1.24e-08 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 5 | 3 | HESX1 |  |  | rs184384746 | 1.24e-08 | rs184384746 | 57226150 | T | C | 0.002 | 5.69 | 1.24e-08 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 5 | 3 | HESX1 |  |  | rs184384746 | 1.24e-08 | rs184384746 | 57226150 | T | C | 0.002 | 5.69 | 1.24e-08 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00014",
      "fields": [
        {
          "field": "Name",
          "value": "rs184384746",
          "confidence": 0.9,
          "evidence": "Row text: 5 | 3 | HESX1 |  |  | rs184384746 | 1.24e-08 | rs184384746 | 57226150 | T | C | 0.002 | 5.69 | 1.24e-08 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.24e-08,
          "confidence": 0.7,
          "evidence": "Row text: 5 | 3 | HESX1 |  |  | rs184384746 | 1.24e-08 | rs184384746 | 57226150 | T | C | 0.002 | 5.69 | 1.24e-08 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 5.69,
          "confidence": 0.65,
          "evidence": "Row text: 5 | 3 | HESX1 |  |  | rs184384746 | 1.24e-08 | rs184384746 | 57226150 | T | C | 0.002 | 5.69 | 1.24e-08 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 5 | 3 | HESX1 |  |  | rs184384746 | 1.24e-08 | rs184384746 | 57226150 | T | C | 0.002 | 5.69 | 1.24e-08 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00015",
      "fields": [
        {
          "field": "Name",
          "value": "rs6448453",
          "confidence": 0.9,
          "evidence": "Row text: 6 | 4 | CLNK | rs6448453 | 0.024 | rs6448451 | 1.19e-08 | rs6448453 | 11026028 | A | G | 0.252 | 6.00 | 1.93e-09 | ?+-+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 0.024,
          "confidence": 0.7,
          "evidence": "Row text: 6 | 4 | CLNK | rs6448453 | 0.024 | rs6448451 | 1.19e-08 | rs6448453 | 11026028 | A | G | 0.252 | 6.00 | 1.93e-09 | ?+-+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 6 | 4 | CLNK | rs6448453 | 0.024 | rs6448451 | 1.19e-08 | rs6448453 | 11026028 | A | G | 0.252 | 6.00 | 1.93e-09 | ?+-+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 6 | 4 | CLNK | rs6448453 | 0.024 | rs6448451 | 1.19e-08 | rs6448453 | 11026028 | A | G | 0.252 | 6.00 | 1.93e-09 | ?+-+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00016",
      "fields": [
        {
          "field": "Name",
          "value": "rs6448451",
          "confidence": 0.9,
          "evidence": "Row text: 6 | 4 | CLNK | rs6448453 | 0.024 | rs6448451 | 1.19e-08 | rs6448453 | 11026028 | A | G | 0.252 | 6.00 | 1.93e-09 | ?+-+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.19e-08,
          "confidence": 0.7,
          "evidence": "Row text: 6 | 4 | CLNK | rs6448453 | 0.024 | rs6448451 | 1.19e-08 | rs6448453 | 11026028 | A | G | 0.252 | 6.00 | 1.93e-09 | ?+-+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 6 | 4 | CLNK | rs6448453 | 0.024 | rs6448451 | 1.19e-08 | rs6448453 | 11026028 | A | G | 0.252 | 6.00 | 1.93e-09 | ?+-+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 6 | 4 | CLNK | rs6448453 | 0.024 | rs6448451 | 1.19e-08 | rs6448453 | 11026028 | A | G | 0.252 | 6.00 | 1.93e-09 | ?+-+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00017",
      "fields": [
        {
          "field": "Name",
          "value": "rs6448453",
          "confidence": 0.9,
          "evidence": "Row text: 6 | 4 | CLNK | rs6448453 | 0.024 | rs6448451 | 1.19e-08 | rs6448453 | 11026028 | A | G | 0.252 | 6.00 | 1.93e-09 | ?+-+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.93e-09,
          "confidence": 0.7,
          "evidence": "Row text: 6 | 4 | CLNK | rs6448453 | 0.024 | rs6448451 | 1.19e-08 | rs6448453 | 11026028 | A | G | 0.252 | 6.00 | 1.93e-09 | ?+-+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 6.0,
          "confidence": 0.65,
          "evidence": "Row text: 6 | 4 | CLNK | rs6448453 | 0.024 | rs6448451 | 1.19e-08 | rs6448453 | 11026028 | A | G | 0.252 | 6.00 | 1.93e-09 | ?+-+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 6 | 4 | CLNK | rs6448453 | 0.024 | rs6448451 | 1.19e-08 | rs6448453 | 11026028 | A | G | 0.252 | 6.00 | 1.93e-09 | ?+-+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00018",
      "fields": [
        {
          "field": "Name",
          "value": "rs7657553",
          "confidence": 0.9,
          "evidence": "Row text: -- | 4 | HS3ST1 | rs7657553 | 2.16e-08 | rs7657553 | 0.79 | rs7657553 | 11723235 | A | G | 0.291 | 1.95 | 0.051 | ?++-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"R",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.16e-08,
          "confidence": 0.7,
          "evidence": "Row text: -- | 4 | HS3ST1 | rs7657553 | 2.16e-08 | rs7657553 | 0.79 | rs7657553 | 11723235 | A | G | 0.291 | 1.95 | 0.051 | ?++-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"R",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: -- | 4 | HS3ST1 | rs7657553 | 2.16e-08 | rs7657553 | 0.79 | rs7657553 | 11723235 | A | G | 0.291 | 1.95 | 0.051 | ?++-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"R",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: -- | 4 | HS3ST1 | rs7657553 | 2.16e-08 | rs7657553 | 0.79 | rs7657553 | 11723235 | A | G | 0.291 | 1.95 | 0.051 | ?++-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"R",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00019",
      "fields": [
        {
          "field": "Name",
          "value": "rs7657553",
          "confidence": 0.9,
          "evidence": "Row text: -- | 4 | HS3ST1 | rs7657553 | 2.16e-08 | rs7657553 | 0.79 | rs7657553 | 11723235 | A | G | 0.291 | 1.95 | 0.051 | ?++-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"R",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 0.79,
          "confidence": 0.7,
          "evidence": "Row text: -- | 4 | HS3ST1 | rs7657553 | 2.16e-08 | rs7657553 | 0.79 | rs7657553 | 11723235 | A | G | 0.291 | 1.95 | 0.051 | ?++-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"R",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: -- | 4 | HS3ST1 | rs7657553 | 2.16e-08 | rs7657553 | 0.79 | rs7657553 | 11723235 | A | G | 0.291 | 1.95 | 0.051 | ?++-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"R",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: -- | 4 | HS3ST1 | rs7657553 | 2.16e-08 | rs7657553 | 0.79 | rs7657553 | 11723235 | A | G | 0.291 | 1.95 | 0.051 | ?++-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"R",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00020",
      "fields": [
        {
          "field": "Name",
          "value": "rs7657553",
          "confidence": 0.9,
          "evidence": "Row text: -- | 4 | HS3ST1 | rs7657553 | 2.16e-08 | rs7657553 | 0.79 | rs7657553 | 11723235 | A | G | 0.291 | 1.95 | 0.051 | ?++-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"R",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 0.051,
          "confidence": 0.7,
          "evidence": "Row text: -- | 4 | HS3ST1 | rs7657553 | 2.16e-08 | rs7657553 | 0.79 | rs7657553 | 11723235 | A | G | 0.291 | 1.95 | 0.051 | ?++-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"R",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 1.95,
          "confidence": 0.65,
          "evidence": "Row text: -- | 4 | HS3ST1 | rs7657553 | 2.16e-08 | rs7657553 | 0.79 | rs7657553 | 11723235 | A | G | 0.291 | 1.95 | 0.051 | ?++-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"R",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: -- | 4 | HS3ST1 | rs7657553 | 2.16e-08 | rs7657553 | 0.79 | rs7657553 | 11723235 | A | G | 0.291 | 1.95 | 0.051 | ?++-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"R",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00021",
      "fields": [
        {
          "field": "Name",
          "value": "rs9269853",
          "confidence": 0.9,
          "evidence": "Row text: 7 | 6 | HLA-DRB1 | rs9269853 | 2.66e-08 | rs6931277 | 1.78e-07 | rs6931277 | 32583357 | T | A | 0.153 | −6.49 | 8.41e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.66e-08,
          "confidence": 0.7,
          "evidence": "Row text: 7 | 6 | HLA-DRB1 | rs9269853 | 2.66e-08 | rs6931277 | 1.78e-07 | rs6931277 | 32583357 | T | A | 0.153 | −6.49 | 8.41e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 7 | 6 | HLA-DRB1 | rs9269853 | 2.66e-08 | rs6931277 | 1.78e-07 | rs6931277 | 32583357 | T | A | 0.153 | −6.49 | 8.41e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 7 | 6 | HLA-DRB1 | rs9269853 | 2.66e-08 | rs6931277 | 1.78e-07 | rs6931277 | 32583357 | T | A | 0.153 | −6.49 | 8.41e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00022",
      "fields": [
        {
          "field": "Name",
          "value": "rs6931277",
          "confidence": 0.9,
          "evidence": "Row text: 7 | 6 | HLA-DRB1 | rs9269853 | 2.66e-08 | rs6931277 | 1.78e-07 | rs6931277 | 32583357 | T | A | 0.153 | −6.49 | 8.41e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.78e-07,
          "confidence": 0.7,
          "evidence": "Row text: 7 | 6 | HLA-DRB1 | rs9269853 | 2.66e-08 | rs6931277 | 1.78e-07 | rs6931277 | 32583357 | T | A | 0.153 | −6.49 | 8.41e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 7 | 6 | HLA-DRB1 | rs9269853 | 2.66e-08 | rs6931277 | 1.78e-07 | rs6931277 | 32583357 | T | A | 0.153 | −6.49 | 8.41e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 7 | 6 | HLA-DRB1 | rs9269853 | 2.66e-08 | rs6931277 | 1.78e-07 | rs6931277 | 32583357 | T | A | 0.153 | −6.49 | 8.41e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00023",
      "fields": [
        {
          "field": "Name",
          "value": "rs6931277",
          "confidence": 0.9,
          "evidence": "Row text: 7 | 6 | HLA-DRB1 | rs9269853 | 2.66e-08 | rs6931277 | 1.78e-07 | rs6931277 | 32583357 | T | A | 0.153 | −6.49 | 8.41e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 8.41e-11,
          "confidence": 0.7,
          "evidence": "Row text: 7 | 6 | HLA-DRB1 | rs9269853 | 2.66e-08 | rs6931277 | 1.78e-07 | rs6931277 | 32583357 | T | A | 0.153 | −6.49 | 8.41e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": -6.49,
          "confidence": 0.65,
          "evidence": "Row text: 7 | 6 | HLA-DRB1 | rs9269853 | 2.66e-08 | rs6931277 | 1.78e-07 | rs6931277 | 32583357 | T | A | 0.153 | −6.49 | 8.41e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 7 | 6 | HLA-DRB1 | rs9269853 | 2.66e-08 | rs6931277 | 1.78e-07 | rs6931277 | 32583357 | T | A | 0.153 | −6.49 | 8.41e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00024",
      "fields": [
        {
          "field": "Name",
          "value": "rs187370608",
          "confidence": 0.9,
          "evidence": "Row text: 8 | 6 | TREM2 |  |  | rs187370608 | 1.45e-16 | rs187370608 | 40942196 | A | G | 0.002 | 8.26 | 1.45e-16 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.45e-16,
          "confidence": 0.7,
          "evidence": "Row text: 8 | 6 | TREM2 |  |  | rs187370608 | 1.45e-16 | rs187370608 | 40942196 | A | G | 0.002 | 8.26 | 1.45e-16 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 8 | 6 | TREM2 |  |  | rs187370608 | 1.45e-16 | rs187370608 | 40942196 | A | G | 0.002 | 8.26 | 1.45e-16 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 8 | 6 | TREM2 |  |  | rs187370608 | 1.45e-16 | rs187370608 | 40942196 | A | G | 0.002 | 8.26 | 1.45e-16 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00025",
      "fields": [
        {
          "field": "Name",
          "value": "rs187370608",
          "confidence": 0.9,
          "evidence": "Row text: 8 | 6 | TREM2 |  |  | rs187370608 | 1.45e-16 | rs187370608 | 40942196 | A | G | 0.002 | 8.26 | 1.45e-16 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.45e-16,
          "confidence": 0.7,
          "evidence": "Row text: 8 | 6 | TREM2 |  |  | rs187370608 | 1.45e-16 | rs187370608 | 40942196 | A | G | 0.002 | 8.26 | 1.45e-16 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 8.26,
          "confidence": 0.65,
          "evidence": "Row text: 8 | 6 | TREM2 |  |  | rs187370608 | 1.45e-16 | rs187370608 | 40942196 | A | G | 0.002 | 8.26 | 1.45e-16 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 8 | 6 | TREM2 |  |  | rs187370608 | 1.45e-16 | rs187370608 | 40942196 | A | G | 0.002 | 8.26 | 1.45e-16 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00026",
      "fields": [
        {
          "field": "Name",
          "value": "rs9381563",
          "confidence": 0.9,
          "evidence": "Row text: 9 | 6 | CD2AP | rs9381563 | 5.35e-09 | rs9381563 | 8.1e-06 | rs9381563 | 47432637 | C | T | 0.355 | 6.33 | 2.52e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 5.35e-09,
          "confidence": 0.7,
          "evidence": "Row text: 9 | 6 | CD2AP | rs9381563 | 5.35e-09 | rs9381563 | 8.1e-06 | rs9381563 | 47432637 | C | T | 0.355 | 6.33 | 2.52e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 9 | 6 | CD2AP | rs9381563 | 5.35e-09 | rs9381563 | 8.1e-06 | rs9381563 | 47432637 | C | T | 0.355 | 6.33 | 2.52e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 9 | 6 | CD2AP | rs9381563 | 5.35e-09 | rs9381563 | 8.1e-06 | rs9381563 | 47432637 | C | T | 0.355 | 6.33 | 2.52e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00027",
      "fields": [
        {
          "field": "Name",
          "value": "rs9381563",
          "confidence": 0.9,
          "evidence": "Row text: 9 | 6 | CD2AP | rs9381563 | 5.35e-09 | rs9381563 | 8.1e-06 | rs9381563 | 47432637 | C | T | 0.355 | 6.33 | 2.52e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 8.1e-06,
          "confidence": 0.7,
          "evidence": "Row text: 9 | 6 | CD2AP | rs9381563 | 5.35e-09 | rs9381563 | 8.1e-06 | rs9381563 | 47432637 | C | T | 0.355 | 6.33 | 2.52e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 9 | 6 | CD2AP | rs9381563 | 5.35e-09 | rs9381563 | 8.1e-06 | rs9381563 | 47432637 | C | T | 0.355 | 6.33 | 2.52e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 9 | 6 | CD2AP | rs9381563 | 5.35e-09 | rs9381563 | 8.1e-06 | rs9381563 | 47432637 | C | T | 0.355 | 6.33 | 2.52e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00028",
      "fields": [
        {
          "field": "Name",
          "value": "rs9381563",
          "confidence": 0.9,
          "evidence": "Row text: 9 | 6 | CD2AP | rs9381563 | 5.35e-09 | rs9381563 | 8.1e-06 | rs9381563 | 47432637 | C | T | 0.355 | 6.33 | 2.52e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.52e-10,
          "confidence": 0.7,
          "evidence": "Row text: 9 | 6 | CD2AP | rs9381563 | 5.35e-09 | rs9381563 | 8.1e-06 | rs9381563 | 47432637 | C | T | 0.355 | 6.33 | 2.52e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 6.33,
          "confidence": 0.65,
          "evidence": "Row text: 9 | 6 | CD2AP | rs9381563 | 5.35e-09 | rs9381563 | 8.1e-06 | rs9381563 | 47432637 | C | T | 0.355 | 6.33 | 2.52e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 9 | 6 | CD2AP | rs9381563 | 5.35e-09 | rs9381563 | 8.1e-06 | rs9381563 | 47432637 | C | T | 0.355 | 6.33 | 2.52e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00029",
      "fields": [
        {
          "field": "Name",
          "value": "rs1859788",
          "confidence": 0.9,
          "evidence": "Row text: 10 | 7 | ZCWPW1 | rs1859788 | 6.05e-09 | rs7384878 | 2.38e-10 | rs1859788 | 99971834 | A | G | 0.31 | −7.93 | 2.22e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 6.05e-09,
          "confidence": 0.7,
          "evidence": "Row text: 10 | 7 | ZCWPW1 | rs1859788 | 6.05e-09 | rs7384878 | 2.38e-10 | rs1859788 | 99971834 | A | G | 0.31 | −7.93 | 2.22e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 10 | 7 | ZCWPW1 | rs1859788 | 6.05e-09 | rs7384878 | 2.38e-10 | rs1859788 | 99971834 | A | G | 0.31 | −7.93 | 2.22e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 10 | 7 | ZCWPW1 | rs1859788 | 6.05e-09 | rs7384878 | 2.38e-10 | rs1859788 | 99971834 | A | G | 0.31 | −7.93 | 2.22e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00030",
      "fields": [
        {
          "field": "Name",
          "value": "rs7384878",
          "confidence": 0.9,
          "evidence": "Row text: 10 | 7 | ZCWPW1 | rs1859788 | 6.05e-09 | rs7384878 | 2.38e-10 | rs1859788 | 99971834 | A | G | 0.31 | −7.93 | 2.22e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.38e-10,
          "confidence": 0.7,
          "evidence": "Row text: 10 | 7 | ZCWPW1 | rs1859788 | 6.05e-09 | rs7384878 | 2.38e-10 | rs1859788 | 99971834 | A | G | 0.31 | −7.93 | 2.22e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 10 | 7 | ZCWPW1 | rs1859788 | 6.05e-09 | rs7384878 | 2.38e-10 | rs1859788 | 99971834 | A | G | 0.31 | −7.93 | 2.22e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 10 | 7 | ZCWPW1 | rs1859788 | 6.05e-09 | rs7384878 | 2.38e-10 | rs1859788 | 99971834 | A | G | 0.31 | −7.93 | 2.22e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00031",
      "fields": [
        {
          "field": "Name",
          "value": "rs1859788",
          "confidence": 0.9,
          "evidence": "Row text: 10 | 7 | ZCWPW1 | rs1859788 | 6.05e-09 | rs7384878 | 2.38e-10 | rs1859788 | 99971834 | A | G | 0.31 | −7.93 | 2.22e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.22e-15,
          "confidence": 0.7,
          "evidence": "Row text: 10 | 7 | ZCWPW1 | rs1859788 | 6.05e-09 | rs7384878 | 2.38e-10 | rs1859788 | 99971834 | A | G | 0.31 | −7.93 | 2.22e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": -7.93,
          "confidence": 0.65,
          "evidence": "Row text: 10 | 7 | ZCWPW1 | rs1859788 | 6.05e-09 | rs7384878 | 2.38e-10 | rs1859788 | 99971834 | A | G | 0.31 | −7.93 | 2.22e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 10 | 7 | ZCWPW1 | rs1859788 | 6.05e-09 | rs7384878 | 2.38e-10 | rs1859788 | 99971834 | A | G | 0.31 | −7.93 | 2.22e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00032",
      "fields": [
        {
          "field": "Name",
          "value": "rs11763230",
          "confidence": 0.9,
          "evidence": "Row text: 11 | 7 | EPHA1 | rs11763230 | 2.58e-11 | rs7810606 | 1.01e-06 | rs7810606 | 143108158 | T | C | 0.5 | −6.62 | 3.59e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.58e-11,
          "confidence": 0.7,
          "evidence": "Row text: 11 | 7 | EPHA1 | rs11763230 | 2.58e-11 | rs7810606 | 1.01e-06 | rs7810606 | 143108158 | T | C | 0.5 | −6.62 | 3.59e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 11 | 7 | EPHA1 | rs11763230 | 2.58e-11 | rs7810606 | 1.01e-06 | rs7810606 | 143108158 | T | C | 0.5 | −6.62 | 3.59e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 11 | 7 | EPHA1 | rs11763230 | 2.58e-11 | rs7810606 | 1.01e-06 | rs7810606 | 143108158 | T | C | 0.5 | −6.62 | 3.59e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00033",
      "fields": [
        {
          "field": "Name",
          "value": "rs7810606",
          "confidence": 0.9,
          "evidence": "Row text: 11 | 7 | EPHA1 | rs11763230 | 2.58e-11 | rs7810606 | 1.01e-06 | rs7810606 | 143108158 | T | C | 0.5 | −6.62 | 3.59e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.01e-06,
          "confidence": 0.7,
          "evidence": "Row text: 11 | 7 | EPHA1 | rs11763230 | 2.58e-11 | rs7810606 | 1.01e-06 | rs7810606 | 143108158 | T | C | 0.5 | −6.62 | 3.59e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 11 | 7 | EPHA1 | rs11763230 | 2.58e-11 | rs7810606 | 1.01e-06 | rs7810606 | 143108158 | T | C | 0.5 | −6.62 | 3.59e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 11 | 7 | EPHA1 | rs11763230 | 2.58e-11 | rs7810606 | 1.01e-06 | rs7810606 | 143108158 | T | C | 0.5 | −6.62 | 3.59e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00034",
      "fields": [
        {
          "field": "Name",
          "value": "rs7810606",
          "confidence": 0.9,
          "evidence": "Row text: 11 | 7 | EPHA1 | rs11763230 | 2.58e-11 | rs7810606 | 1.01e-06 | rs7810606 | 143108158 | T | C | 0.5 | −6.62 | 3.59e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 3.59e-11,
          "confidence": 0.7,
          "evidence": "Row text: 11 | 7 | EPHA1 | rs11763230 | 2.58e-11 | rs7810606 | 1.01e-06 | rs7810606 | 143108158 | T | C | 0.5 | −6.62 | 3.59e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": -6.62,
          "confidence": 0.65,
          "evidence": "Row text: 11 | 7 | EPHA1 | rs11763230 | 2.58e-11 | rs7810606 | 1.01e-06 | rs7810606 | 143108158 | T | C | 0.5 | −6.62 | 3.59e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 11 | 7 | EPHA1 | rs11763230 | 2.58e-11 | rs7810606 | 1.01e-06 | rs7810606 | 143108158 | T | C | 0.5 | −6.62 | 3.59e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locu",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00035",
      "fields": [
        {
          "field": "Name",
          "value": "rs114360492",
          "confidence": 0.9,
          "evidence": "Row text: 12 | 7 | CNTNAP2 |  |  | rs114360492 | 2.1e-09 | rs114360492 | 145950029 | T | C | 0.0 | 5.99 | 2.1e-09 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.1e-09,
          "confidence": 0.7,
          "evidence": "Row text: 12 | 7 | CNTNAP2 |  |  | rs114360492 | 2.1e-09 | rs114360492 | 145950029 | T | C | 0.0 | 5.99 | 2.1e-09 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 12 | 7 | CNTNAP2 |  |  | rs114360492 | 2.1e-09 | rs114360492 | 145950029 | T | C | 0.0 | 5.99 | 2.1e-09 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 12 | 7 | CNTNAP2 |  |  | rs114360492 | 2.1e-09 | rs114360492 | 145950029 | T | C | 0.0 | 5.99 | 2.1e-09 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00036",
      "fields": [
        {
          "field": "Name",
          "value": "rs114360492",
          "confidence": 0.9,
          "evidence": "Row text: 12 | 7 | CNTNAP2 |  |  | rs114360492 | 2.1e-09 | rs114360492 | 145950029 | T | C | 0.0 | 5.99 | 2.1e-09 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.1e-09,
          "confidence": 0.7,
          "evidence": "Row text: 12 | 7 | CNTNAP2 |  |  | rs114360492 | 2.1e-09 | rs114360492 | 145950029 | T | C | 0.0 | 5.99 | 2.1e-09 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 5.99,
          "confidence": 0.65,
          "evidence": "Row text: 12 | 7 | CNTNAP2 |  |  | rs114360492 | 2.1e-09 | rs114360492 | 145950029 | T | C | 0.0 | 5.99 | 2.1e-09 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 12 | 7 | CNTNAP2 |  |  | rs114360492 | 2.1e-09 | rs114360492 | 145950029 | T | C | 0.0 | 5.99 | 2.1e-09 | ???+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, \"Region | ",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00037",
      "fields": [
        {
          "field": "Name",
          "value": "rs4236673",
          "confidence": 0.9,
          "evidence": "Row text: 13 | 8 | CLU/PTK2B | rs4236673 | 6.36e-20 | rs1532278 | 7.45e-09 | rs4236673 | 27464929 | A | G | 0.391 | −8.98 | 2.61e-19 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 6.36e-20,
          "confidence": 0.7,
          "evidence": "Row text: 13 | 8 | CLU/PTK2B | rs4236673 | 6.36e-20 | rs1532278 | 7.45e-09 | rs4236673 | 27464929 | A | G | 0.391 | −8.98 | 2.61e-19 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 13 | 8 | CLU/PTK2B | rs4236673 | 6.36e-20 | rs1532278 | 7.45e-09 | rs4236673 | 27464929 | A | G | 0.391 | −8.98 | 2.61e-19 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 13 | 8 | CLU/PTK2B | rs4236673 | 6.36e-20 | rs1532278 | 7.45e-09 | rs4236673 | 27464929 | A | G | 0.391 | −8.98 | 2.61e-19 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00038",
      "fields": [
        {
          "field": "Name",
          "value": "rs1532278",
          "confidence": 0.9,
          "evidence": "Row text: 13 | 8 | CLU/PTK2B | rs4236673 | 6.36e-20 | rs1532278 | 7.45e-09 | rs4236673 | 27464929 | A | G | 0.391 | −8.98 | 2.61e-19 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 7.45e-09,
          "confidence": 0.7,
          "evidence": "Row text: 13 | 8 | CLU/PTK2B | rs4236673 | 6.36e-20 | rs1532278 | 7.45e-09 | rs4236673 | 27464929 | A | G | 0.391 | −8.98 | 2.61e-19 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 13 | 8 | CLU/PTK2B | rs4236673 | 6.36e-20 | rs1532278 | 7.45e-09 | rs4236673 | 27464929 | A | G | 0.391 | −8.98 | 2.61e-19 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 13 | 8 | CLU/PTK2B | rs4236673 | 6.36e-20 | rs1532278 | 7.45e-09 | rs4236673 | 27464929 | A | G | 0.391 | −8.98 | 2.61e-19 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00039",
      "fields": [
        {
          "field": "Name",
          "value": "rs4236673",
          "confidence": 0.9,
          "evidence": "Row text: 13 | 8 | CLU/PTK2B | rs4236673 | 6.36e-20 | rs1532278 | 7.45e-09 | rs4236673 | 27464929 | A | G | 0.391 | −8.98 | 2.61e-19 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.61e-19,
          "confidence": 0.7,
          "evidence": "Row text: 13 | 8 | CLU/PTK2B | rs4236673 | 6.36e-20 | rs1532278 | 7.45e-09 | rs4236673 | 27464929 | A | G | 0.391 | −8.98 | 2.61e-19 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": -8.98,
          "confidence": 0.65,
          "evidence": "Row text: 13 | 8 | CLU/PTK2B | rs4236673 | 6.36e-20 | rs1532278 | 7.45e-09 | rs4236673 | 27464929 | A | G | 0.391 | −8.98 | 2.61e-19 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 13 | 8 | CLU/PTK2B | rs4236673 | 6.36e-20 | rs1532278 | 7.45e-09 | rs4236673 | 27464929 | A | G | 0.391 | −8.98 | 2.61e-19 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00040",
      "fields": [
        {
          "field": "Name",
          "value": "rs11257242",
          "confidence": 0.9,
          "evidence": "Row text: 14 | 10 | ECHDC3 | rs11257242 | 2.38e-08 | rs11257238 | 5.84e-05 | rs11257238 | 11717397 | C | T | 0.375 | 5.69 | 1.26e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.38e-08,
          "confidence": 0.7,
          "evidence": "Row text: 14 | 10 | ECHDC3 | rs11257242 | 2.38e-08 | rs11257238 | 5.84e-05 | rs11257238 | 11717397 | C | T | 0.375 | 5.69 | 1.26e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 14 | 10 | ECHDC3 | rs11257242 | 2.38e-08 | rs11257238 | 5.84e-05 | rs11257238 | 11717397 | C | T | 0.375 | 5.69 | 1.26e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 14 | 10 | ECHDC3 | rs11257242 | 2.38e-08 | rs11257238 | 5.84e-05 | rs11257238 | 11717397 | C | T | 0.375 | 5.69 | 1.26e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00041",
      "fields": [
        {
          "field": "Name",
          "value": "rs11257238",
          "confidence": 0.9,
          "evidence": "Row text: 14 | 10 | ECHDC3 | rs11257242 | 2.38e-08 | rs11257238 | 5.84e-05 | rs11257238 | 11717397 | C | T | 0.375 | 5.69 | 1.26e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 5.84e-05,
          "confidence": 0.7,
          "evidence": "Row text: 14 | 10 | ECHDC3 | rs11257242 | 2.38e-08 | rs11257238 | 5.84e-05 | rs11257238 | 11717397 | C | T | 0.375 | 5.69 | 1.26e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 14 | 10 | ECHDC3 | rs11257242 | 2.38e-08 | rs11257238 | 5.84e-05 | rs11257238 | 11717397 | C | T | 0.375 | 5.69 | 1.26e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 14 | 10 | ECHDC3 | rs11257242 | 2.38e-08 | rs11257238 | 5.84e-05 | rs11257238 | 11717397 | C | T | 0.375 | 5.69 | 1.26e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00042",
      "fields": [
        {
          "field": "Name",
          "value": "rs11257238",
          "confidence": 0.9,
          "evidence": "Row text: 14 | 10 | ECHDC3 | rs11257242 | 2.38e-08 | rs11257238 | 5.84e-05 | rs11257238 | 11717397 | C | T | 0.375 | 5.69 | 1.26e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.26e-08,
          "confidence": 0.7,
          "evidence": "Row text: 14 | 10 | ECHDC3 | rs11257242 | 2.38e-08 | rs11257238 | 5.84e-05 | rs11257238 | 11717397 | C | T | 0.375 | 5.69 | 1.26e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 5.69,
          "confidence": 0.65,
          "evidence": "Row text: 14 | 10 | ECHDC3 | rs11257242 | 2.38e-08 | rs11257238 | 5.84e-05 | rs11257238 | 11717397 | C | T | 0.375 | 5.69 | 1.26e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 14 | 10 | ECHDC3 | rs11257242 | 2.38e-08 | rs11257238 | 5.84e-05 | rs11257238 | 11717397 | C | T | 0.375 | 5.69 | 1.26e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00043",
      "fields": [
        {
          "field": "Name",
          "value": "rs7935829",
          "confidence": 0.9,
          "evidence": "Row text: 15 | 11 | MS4A6A | rs7935829 | 8.21e-13 | rs1582763 | 4.72e-09 | rs2081545 | 59958380 | A | C | 0.381 | −7.97 | 1.55e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 8.21e-13,
          "confidence": 0.7,
          "evidence": "Row text: 15 | 11 | MS4A6A | rs7935829 | 8.21e-13 | rs1582763 | 4.72e-09 | rs2081545 | 59958380 | A | C | 0.381 | −7.97 | 1.55e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 15 | 11 | MS4A6A | rs7935829 | 8.21e-13 | rs1582763 | 4.72e-09 | rs2081545 | 59958380 | A | C | 0.381 | −7.97 | 1.55e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 15 | 11 | MS4A6A | rs7935829 | 8.21e-13 | rs1582763 | 4.72e-09 | rs2081545 | 59958380 | A | C | 0.381 | −7.97 | 1.55e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00044",
      "fields": [
        {
          "field": "Name",
          "value": "rs1582763",
          "confidence": 0.9,
          "evidence": "Row text: 15 | 11 | MS4A6A | rs7935829 | 8.21e-13 | rs1582763 | 4.72e-09 | rs2081545 | 59958380 | A | C | 0.381 | −7.97 | 1.55e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 4.72e-09,
          "confidence": 0.7,
          "evidence": "Row text: 15 | 11 | MS4A6A | rs7935829 | 8.21e-13 | rs1582763 | 4.72e-09 | rs2081545 | 59958380 | A | C | 0.381 | −7.97 | 1.55e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 15 | 11 | MS4A6A | rs7935829 | 8.21e-13 | rs1582763 | 4.72e-09 | rs2081545 | 59958380 | A | C | 0.381 | −7.97 | 1.55e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 15 | 11 | MS4A6A | rs7935829 | 8.21e-13 | rs1582763 | 4.72e-09 | rs2081545 | 59958380 | A | C | 0.381 | −7.97 | 1.55e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00045",
      "fields": [
        {
          "field": "Name",
          "value": "rs2081545",
          "confidence": 0.9,
          "evidence": "Row text: 15 | 11 | MS4A6A | rs7935829 | 8.21e-13 | rs1582763 | 4.72e-09 | rs2081545 | 59958380 | A | C | 0.381 | −7.97 | 1.55e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.55e-15,
          "confidence": 0.7,
          "evidence": "Row text: 15 | 11 | MS4A6A | rs7935829 | 8.21e-13 | rs1582763 | 4.72e-09 | rs2081545 | 59958380 | A | C | 0.381 | −7.97 | 1.55e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": -7.97,
          "confidence": 0.65,
          "evidence": "Row text: 15 | 11 | MS4A6A | rs7935829 | 8.21e-13 | rs1582763 | 4.72e-09 | rs2081545 | 59958380 | A | C | 0.381 | −7.97 | 1.55e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 15 | 11 | MS4A6A | rs7935829 | 8.21e-13 | rs1582763 | 4.72e-09 | rs2081545 | 59958380 | A | C | 0.381 | −7.97 | 1.55e-15 | ----\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00046",
      "fields": [
        {
          "field": "Name",
          "value": "rs10792832",
          "confidence": 0.9,
          "evidence": "Row text: 16 | 11 | PICALM | rs10792832 | 1.12e-17 | rs3844143 | 5.31e-11 | rs867611 | 85776544 | G | A | 0.314 | −8.75 | 2.19e-18 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.12e-17,
          "confidence": 0.7,
          "evidence": "Row text: 16 | 11 | PICALM | rs10792832 | 1.12e-17 | rs3844143 | 5.31e-11 | rs867611 | 85776544 | G | A | 0.314 | −8.75 | 2.19e-18 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 16 | 11 | PICALM | rs10792832 | 1.12e-17 | rs3844143 | 5.31e-11 | rs867611 | 85776544 | G | A | 0.314 | −8.75 | 2.19e-18 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 16 | 11 | PICALM | rs10792832 | 1.12e-17 | rs3844143 | 5.31e-11 | rs867611 | 85776544 | G | A | 0.314 | −8.75 | 2.19e-18 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00047",
      "fields": [
        {
          "field": "Name",
          "value": "rs3844143",
          "confidence": 0.9,
          "evidence": "Row text: 16 | 11 | PICALM | rs10792832 | 1.12e-17 | rs3844143 | 5.31e-11 | rs867611 | 85776544 | G | A | 0.314 | −8.75 | 2.19e-18 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 5.31e-11,
          "confidence": 0.7,
          "evidence": "Row text: 16 | 11 | PICALM | rs10792832 | 1.12e-17 | rs3844143 | 5.31e-11 | rs867611 | 85776544 | G | A | 0.314 | −8.75 | 2.19e-18 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 16 | 11 | PICALM | rs10792832 | 1.12e-17 | rs3844143 | 5.31e-11 | rs867611 | 85776544 | G | A | 0.314 | −8.75 | 2.19e-18 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 16 | 11 | PICALM | rs10792832 | 1.12e-17 | rs3844143 | 5.31e-11 | rs867611 | 85776544 | G | A | 0.314 | −8.75 | 2.19e-18 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00048",
      "fields": [
        {
          "field": "Name",
          "value": "rs867611",
          "confidence": 0.9,
          "evidence": "Row text: 16 | 11 | PICALM | rs10792832 | 1.12e-17 | rs3844143 | 5.31e-11 | rs867611 | 85776544 | G | A | 0.314 | −8.75 | 2.19e-18 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.19e-18,
          "confidence": 0.7,
          "evidence": "Row text: 16 | 11 | PICALM | rs10792832 | 1.12e-17 | rs3844143 | 5.31e-11 | rs867611 | 85776544 | G | A | 0.314 | −8.75 | 2.19e-18 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": -8.75,
          "confidence": 0.65,
          "evidence": "Row text: 16 | 11 | PICALM | rs10792832 | 1.12e-17 | rs3844143 | 5.31e-11 | rs867611 | 85776544 | G | A | 0.314 | −8.75 | 2.19e-18 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 16 | 11 | PICALM | rs10792832 | 1.12e-17 | rs3844143 | 5.31e-11 | rs867611 | 85776544 | G | A | 0.314 | −8.75 | 2.19e-18 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00049",
      "fields": [
        {
          "field": "Name",
          "value": "rs11218343",
          "confidence": 0.9,
          "evidence": "Row text: 17 | 11 | SORL1 | rs11218343 | 5.57e-11 | rs11218343 | 2.81e-06 | rs11218343 | 121435587 | C | T | 0.04 | −6.79 | 1.09e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 5.57e-11,
          "confidence": 0.7,
          "evidence": "Row text: 17 | 11 | SORL1 | rs11218343 | 5.57e-11 | rs11218343 | 2.81e-06 | rs11218343 | 121435587 | C | T | 0.04 | −6.79 | 1.09e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 17 | 11 | SORL1 | rs11218343 | 5.57e-11 | rs11218343 | 2.81e-06 | rs11218343 | 121435587 | C | T | 0.04 | −6.79 | 1.09e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 17 | 11 | SORL1 | rs11218343 | 5.57e-11 | rs11218343 | 2.81e-06 | rs11218343 | 121435587 | C | T | 0.04 | −6.79 | 1.09e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00050",
      "fields": [
        {
          "field": "Name",
          "value": "rs11218343",
          "confidence": 0.9,
          "evidence": "Row text: 17 | 11 | SORL1 | rs11218343 | 5.57e-11 | rs11218343 | 2.81e-06 | rs11218343 | 121435587 | C | T | 0.04 | −6.79 | 1.09e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.81e-06,
          "confidence": 0.7,
          "evidence": "Row text: 17 | 11 | SORL1 | rs11218343 | 5.57e-11 | rs11218343 | 2.81e-06 | rs11218343 | 121435587 | C | T | 0.04 | −6.79 | 1.09e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 17 | 11 | SORL1 | rs11218343 | 5.57e-11 | rs11218343 | 2.81e-06 | rs11218343 | 121435587 | C | T | 0.04 | −6.79 | 1.09e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 17 | 11 | SORL1 | rs11218343 | 5.57e-11 | rs11218343 | 2.81e-06 | rs11218343 | 121435587 | C | T | 0.04 | −6.79 | 1.09e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00051",
      "fields": [
        {
          "field": "Name",
          "value": "rs11218343",
          "confidence": 0.9,
          "evidence": "Row text: 17 | 11 | SORL1 | rs11218343 | 5.57e-11 | rs11218343 | 2.81e-06 | rs11218343 | 121435587 | C | T | 0.04 | −6.79 | 1.09e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.09e-11,
          "confidence": 0.7,
          "evidence": "Row text: 17 | 11 | SORL1 | rs11218343 | 5.57e-11 | rs11218343 | 2.81e-06 | rs11218343 | 121435587 | C | T | 0.04 | −6.79 | 1.09e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": -6.79,
          "confidence": 0.65,
          "evidence": "Row text: 17 | 11 | SORL1 | rs11218343 | 5.57e-11 | rs11218343 | 2.81e-06 | rs11218343 | 121435587 | C | T | 0.04 | −6.79 | 1.09e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 17 | 11 | SORL1 | rs11218343 | 5.57e-11 | rs11218343 | 2.81e-06 | rs11218343 | 121435587 | C | T | 0.04 | −6.79 | 1.09e-11 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00052",
      "fields": [
        {
          "field": "Name",
          "value": "rs12590654",
          "confidence": 0.9,
          "evidence": "Row text: 18 | 14 | SLC24A4 | rs12590654 | 1.98e-08 | rs12590654 | 3.7e-06 | rs12590654 | 92938855 | A | G | 0.344 | −6.39 | 1.65e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": ",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.98e-08,
          "confidence": 0.7,
          "evidence": "Row text: 18 | 14 | SLC24A4 | rs12590654 | 1.98e-08 | rs12590654 | 3.7e-06 | rs12590654 | 92938855 | A | G | 0.344 | −6.39 | 1.65e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": ",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 18 | 14 | SLC24A4 | rs12590654 | 1.98e-08 | rs12590654 | 3.7e-06 | rs12590654 | 92938855 | A | G | 0.344 | −6.39 | 1.65e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": ",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 18 | 14 | SLC24A4 | rs12590654 | 1.98e-08 | rs12590654 | 3.7e-06 | rs12590654 | 92938855 | A | G | 0.344 | −6.39 | 1.65e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": ",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00053",
      "fields": [
        {
          "field": "Name",
          "value": "rs12590654",
          "confidence": 0.9,
          "evidence": "Row text: 18 | 14 | SLC24A4 | rs12590654 | 1.98e-08 | rs12590654 | 3.7e-06 | rs12590654 | 92938855 | A | G | 0.344 | −6.39 | 1.65e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": ",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 3.7e-06,
          "confidence": 0.7,
          "evidence": "Row text: 18 | 14 | SLC24A4 | rs12590654 | 1.98e-08 | rs12590654 | 3.7e-06 | rs12590654 | 92938855 | A | G | 0.344 | −6.39 | 1.65e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": ",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 18 | 14 | SLC24A4 | rs12590654 | 1.98e-08 | rs12590654 | 3.7e-06 | rs12590654 | 92938855 | A | G | 0.344 | −6.39 | 1.65e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": ",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 18 | 14 | SLC24A4 | rs12590654 | 1.98e-08 | rs12590654 | 3.7e-06 | rs12590654 | 92938855 | A | G | 0.344 | −6.39 | 1.65e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": ",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00054",
      "fields": [
        {
          "field": "Name",
          "value": "rs12590654",
          "confidence": 0.9,
          "evidence": "Row text: 18 | 14 | SLC24A4 | rs12590654 | 1.98e-08 | rs12590654 | 3.7e-06 | rs12590654 | 92938855 | A | G | 0.344 | −6.39 | 1.65e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": ",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.65e-10,
          "confidence": 0.7,
          "evidence": "Row text: 18 | 14 | SLC24A4 | rs12590654 | 1.98e-08 | rs12590654 | 3.7e-06 | rs12590654 | 92938855 | A | G | 0.344 | −6.39 | 1.65e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": ",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": -6.39,
          "confidence": 0.65,
          "evidence": "Row text: 18 | 14 | SLC24A4 | rs12590654 | 1.98e-08 | rs12590654 | 3.7e-06 | rs12590654 | 92938855 | A | G | 0.344 | −6.39 | 1.65e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": ",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 18 | 14 | SLC24A4 | rs12590654 | 1.98e-08 | rs12590654 | 3.7e-06 | rs12590654 | 92938855 | A | G | 0.344 | −6.39 | 1.65e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": ",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00055",
      "fields": [
        {
          "field": "Name",
          "value": "rs442495",
          "confidence": 0.9,
          "evidence": "Row text: 19 | 15 | ADAM10 | rs442495 | 0.000309 | rs442495 | 2.65e-07 | rs442495 | 59022615 | C | T | 0.32 | −6.07 | 1.31e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 0.000309,
          "confidence": 0.7,
          "evidence": "Row text: 19 | 15 | ADAM10 | rs442495 | 0.000309 | rs442495 | 2.65e-07 | rs442495 | 59022615 | C | T | 0.32 | −6.07 | 1.31e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 19 | 15 | ADAM10 | rs442495 | 0.000309 | rs442495 | 2.65e-07 | rs442495 | 59022615 | C | T | 0.32 | −6.07 | 1.31e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 19 | 15 | ADAM10 | rs442495 | 0.000309 | rs442495 | 2.65e-07 | rs442495 | 59022615 | C | T | 0.32 | −6.07 | 1.31e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00056",
      "fields": [
        {
          "field": "Name",
          "value": "rs442495",
          "confidence": 0.9,
          "evidence": "Row text: 19 | 15 | ADAM10 | rs442495 | 0.000309 | rs442495 | 2.65e-07 | rs442495 | 59022615 | C | T | 0.32 | −6.07 | 1.31e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.65e-07,
          "confidence": 0.7,
          "evidence": "Row text: 19 | 15 | ADAM10 | rs442495 | 0.000309 | rs442495 | 2.65e-07 | rs442495 | 59022615 | C | T | 0.32 | −6.07 | 1.31e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 19 | 15 | ADAM10 | rs442495 | 0.000309 | rs442495 | 2.65e-07 | rs442495 | 59022615 | C | T | 0.32 | −6.07 | 1.31e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 19 | 15 | ADAM10 | rs442495 | 0.000309 | rs442495 | 2.65e-07 | rs442495 | 59022615 | C | T | 0.32 | −6.07 | 1.31e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00057",
      "fields": [
        {
          "field": "Name",
          "value": "rs442495",
          "confidence": 0.9,
          "evidence": "Row text: 19 | 15 | ADAM10 | rs442495 | 0.000309 | rs442495 | 2.65e-07 | rs442495 | 59022615 | C | T | 0.32 | −6.07 | 1.31e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.31e-09,
          "confidence": 0.7,
          "evidence": "Row text: 19 | 15 | ADAM10 | rs442495 | 0.000309 | rs442495 | 2.65e-07 | rs442495 | 59022615 | C | T | 0.32 | −6.07 | 1.31e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": -6.07,
          "confidence": 0.65,
          "evidence": "Row text: 19 | 15 | ADAM10 | rs442495 | 0.000309 | rs442495 | 2.65e-07 | rs442495 | 59022615 | C | T | 0.32 | −6.07 | 1.31e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 19 | 15 | ADAM10 | rs442495 | 0.000309 | rs442495 | 2.65e-07 | rs442495 | 59022615 | C | T | 0.32 | −6.07 | 1.31e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00058",
      "fields": [
        {
          "field": "Name",
          "value": "rs117618017",
          "confidence": 0.9,
          "evidence": "Row text: 20 | 15 | APH1B | rs117618017 | 0.022 | rs117618017 | 2.64e-07 | rs117618017 | 63569902 | T | C | 0.132 | 5.52 | 3.35e-08 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 0.022,
          "confidence": 0.7,
          "evidence": "Row text: 20 | 15 | APH1B | rs117618017 | 0.022 | rs117618017 | 2.64e-07 | rs117618017 | 63569902 | T | C | 0.132 | 5.52 | 3.35e-08 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 20 | 15 | APH1B | rs117618017 | 0.022 | rs117618017 | 2.64e-07 | rs117618017 | 63569902 | T | C | 0.132 | 5.52 | 3.35e-08 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 20 | 15 | APH1B | rs117618017 | 0.022 | rs117618017 | 2.64e-07 | rs117618017 | 63569902 | T | C | 0.132 | 5.52 | 3.35e-08 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00059",
      "fields": [
        {
          "field": "Name",
          "value": "rs117618017",
          "confidence": 0.9,
          "evidence": "Row text: 20 | 15 | APH1B | rs117618017 | 0.022 | rs117618017 | 2.64e-07 | rs117618017 | 63569902 | T | C | 0.132 | 5.52 | 3.35e-08 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.64e-07,
          "confidence": 0.7,
          "evidence": "Row text: 20 | 15 | APH1B | rs117618017 | 0.022 | rs117618017 | 2.64e-07 | rs117618017 | 63569902 | T | C | 0.132 | 5.52 | 3.35e-08 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 20 | 15 | APH1B | rs117618017 | 0.022 | rs117618017 | 2.64e-07 | rs117618017 | 63569902 | T | C | 0.132 | 5.52 | 3.35e-08 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 20 | 15 | APH1B | rs117618017 | 0.022 | rs117618017 | 2.64e-07 | rs117618017 | 63569902 | T | C | 0.132 | 5.52 | 3.35e-08 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00060",
      "fields": [
        {
          "field": "Name",
          "value": "rs117618017",
          "confidence": 0.9,
          "evidence": "Row text: 20 | 15 | APH1B | rs117618017 | 0.022 | rs117618017 | 2.64e-07 | rs117618017 | 63569902 | T | C | 0.132 | 5.52 | 3.35e-08 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 3.35e-08,
          "confidence": 0.7,
          "evidence": "Row text: 20 | 15 | APH1B | rs117618017 | 0.022 | rs117618017 | 2.64e-07 | rs117618017 | 63569902 | T | C | 0.132 | 5.52 | 3.35e-08 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 5.52,
          "confidence": 0.65,
          "evidence": "Row text: 20 | 15 | APH1B | rs117618017 | 0.022 | rs117618017 | 2.64e-07 | rs117618017 | 63569902 | T | C | 0.132 | 5.52 | 3.35e-08 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 20 | 15 | APH1B | rs117618017 | 0.022 | rs117618017 | 2.64e-07 | rs117618017 | 63569902 | T | C | 0.132 | 5.52 | 3.35e-08 | ++++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00061",
      "fields": [
        {
          "field": "Name",
          "value": "rs59735493",
          "confidence": 0.9,
          "evidence": "Row text: 21 | 16 | KAT8 | rs59735493 | 0.000825 | rs59735493 | 3.72e-06 | rs59735493 | 31133100 | A | G | 0.3 | −5.49 | 3.98e-08 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 0.000825,
          "confidence": 0.7,
          "evidence": "Row text: 21 | 16 | KAT8 | rs59735493 | 0.000825 | rs59735493 | 3.72e-06 | rs59735493 | 31133100 | A | G | 0.3 | −5.49 | 3.98e-08 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 21 | 16 | KAT8 | rs59735493 | 0.000825 | rs59735493 | 3.72e-06 | rs59735493 | 31133100 | A | G | 0.3 | −5.49 | 3.98e-08 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 21 | 16 | KAT8 | rs59735493 | 0.000825 | rs59735493 | 3.72e-06 | rs59735493 | 31133100 | A | G | 0.3 | −5.49 | 3.98e-08 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00062",
      "fields": [
        {
          "field": "Name",
          "value": "rs59735493",
          "confidence": 0.9,
          "evidence": "Row text: 21 | 16 | KAT8 | rs59735493 | 0.000825 | rs59735493 | 3.72e-06 | rs59735493 | 31133100 | A | G | 0.3 | −5.49 | 3.98e-08 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 3.72e-06,
          "confidence": 0.7,
          "evidence": "Row text: 21 | 16 | KAT8 | rs59735493 | 0.000825 | rs59735493 | 3.72e-06 | rs59735493 | 31133100 | A | G | 0.3 | −5.49 | 3.98e-08 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 21 | 16 | KAT8 | rs59735493 | 0.000825 | rs59735493 | 3.72e-06 | rs59735493 | 31133100 | A | G | 0.3 | −5.49 | 3.98e-08 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 21 | 16 | KAT8 | rs59735493 | 0.000825 | rs59735493 | 3.72e-06 | rs59735493 | 31133100 | A | G | 0.3 | −5.49 | 3.98e-08 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00063",
      "fields": [
        {
          "field": "Name",
          "value": "rs59735493",
          "confidence": 0.9,
          "evidence": "Row text: 21 | 16 | KAT8 | rs59735493 | 0.000825 | rs59735493 | 3.72e-06 | rs59735493 | 31133100 | A | G | 0.3 | −5.49 | 3.98e-08 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 3.98e-08,
          "confidence": 0.7,
          "evidence": "Row text: 21 | 16 | KAT8 | rs59735493 | 0.000825 | rs59735493 | 3.72e-06 | rs59735493 | 31133100 | A | G | 0.3 | −5.49 | 3.98e-08 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": -5.49,
          "confidence": 0.65,
          "evidence": "Row text: 21 | 16 | KAT8 | rs59735493 | 0.000825 | rs59735493 | 3.72e-06 | rs59735493 | 31133100 | A | G | 0.3 | −5.49 | 3.98e-08 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 21 | 16 | KAT8 | rs59735493 | 0.000825 | rs59735493 | 3.72e-06 | rs59735493 | 31133100 | A | G | 0.3 | −5.49 | 3.98e-08 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00064",
      "fields": [
        {
          "field": "Name",
          "value": "rs113260531",
          "confidence": 0.9,
          "evidence": "Row text: 22 | 17 | SCIMP | rs113260531 | 3.21e-06 | rs9916042 | 4.73e-08 | rs113260531 | 5138980 | A | G | 0.12 | 6.12 | 9.16e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 3.21e-06,
          "confidence": 0.7,
          "evidence": "Row text: 22 | 17 | SCIMP | rs113260531 | 3.21e-06 | rs9916042 | 4.73e-08 | rs113260531 | 5138980 | A | G | 0.12 | 6.12 | 9.16e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 22 | 17 | SCIMP | rs113260531 | 3.21e-06 | rs9916042 | 4.73e-08 | rs113260531 | 5138980 | A | G | 0.12 | 6.12 | 9.16e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 22 | 17 | SCIMP | rs113260531 | 3.21e-06 | rs9916042 | 4.73e-08 | rs113260531 | 5138980 | A | G | 0.12 | 6.12 | 9.16e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00065",
      "fields": [
        {
          "field": "Name",
          "value": "rs9916042",
          "confidence": 0.9,
          "evidence": "Row text: 22 | 17 | SCIMP | rs113260531 | 3.21e-06 | rs9916042 | 4.73e-08 | rs113260531 | 5138980 | A | G | 0.12 | 6.12 | 9.16e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 4.73e-08,
          "confidence": 0.7,
          "evidence": "Row text: 22 | 17 | SCIMP | rs113260531 | 3.21e-06 | rs9916042 | 4.73e-08 | rs113260531 | 5138980 | A | G | 0.12 | 6.12 | 9.16e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 22 | 17 | SCIMP | rs113260531 | 3.21e-06 | rs9916042 | 4.73e-08 | rs113260531 | 5138980 | A | G | 0.12 | 6.12 | 9.16e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 22 | 17 | SCIMP | rs113260531 | 3.21e-06 | rs9916042 | 4.73e-08 | rs113260531 | 5138980 | A | G | 0.12 | 6.12 | 9.16e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00066",
      "fields": [
        {
          "field": "Name",
          "value": "rs113260531",
          "confidence": 0.9,
          "evidence": "Row text: 22 | 17 | SCIMP | rs113260531 | 3.21e-06 | rs9916042 | 4.73e-08 | rs113260531 | 5138980 | A | G | 0.12 | 6.12 | 9.16e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 9.16e-10,
          "confidence": 0.7,
          "evidence": "Row text: 22 | 17 | SCIMP | rs113260531 | 3.21e-06 | rs9916042 | 4.73e-08 | rs113260531 | 5138980 | A | G | 0.12 | 6.12 | 9.16e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 6.12,
          "confidence": 0.65,
          "evidence": "Row text: 22 | 17 | SCIMP | rs113260531 | 3.21e-06 | rs9916042 | 4.73e-08 | rs113260531 | 5138980 | A | G | 0.12 | 6.12 | 9.16e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 22 | 17 | SCIMP | rs113260531 | 3.21e-06 | rs9916042 | 4.73e-08 | rs113260531 | 5138980 | A | G | 0.12 | 6.12 | 9.16e-10 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Lo",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00067",
      "fields": [
        {
          "field": "Name",
          "value": "rs28394864",
          "confidence": 0.9,
          "evidence": "Row text: 23 | 17 | ABI3 | rs28394864 | 7.29e-05 | rs28394864 | 6.8e-06 | rs28394864 | 47450775 | A | G | 0.473 | 5.62 | 1.87e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 7.29e-05,
          "confidence": 0.7,
          "evidence": "Row text: 23 | 17 | ABI3 | rs28394864 | 7.29e-05 | rs28394864 | 6.8e-06 | rs28394864 | 47450775 | A | G | 0.473 | 5.62 | 1.87e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 23 | 17 | ABI3 | rs28394864 | 7.29e-05 | rs28394864 | 6.8e-06 | rs28394864 | 47450775 | A | G | 0.473 | 5.62 | 1.87e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 23 | 17 | ABI3 | rs28394864 | 7.29e-05 | rs28394864 | 6.8e-06 | rs28394864 | 47450775 | A | G | 0.473 | 5.62 | 1.87e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00068",
      "fields": [
        {
          "field": "Name",
          "value": "rs28394864",
          "confidence": 0.9,
          "evidence": "Row text: 23 | 17 | ABI3 | rs28394864 | 7.29e-05 | rs28394864 | 6.8e-06 | rs28394864 | 47450775 | A | G | 0.473 | 5.62 | 1.87e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 6.8e-06,
          "confidence": 0.7,
          "evidence": "Row text: 23 | 17 | ABI3 | rs28394864 | 7.29e-05 | rs28394864 | 6.8e-06 | rs28394864 | 47450775 | A | G | 0.473 | 5.62 | 1.87e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 23 | 17 | ABI3 | rs28394864 | 7.29e-05 | rs28394864 | 6.8e-06 | rs28394864 | 47450775 | A | G | 0.473 | 5.62 | 1.87e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 23 | 17 | ABI3 | rs28394864 | 7.29e-05 | rs28394864 | 6.8e-06 | rs28394864 | 47450775 | A | G | 0.473 | 5.62 | 1.87e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00069",
      "fields": [
        {
          "field": "Name",
          "value": "rs28394864",
          "confidence": 0.9,
          "evidence": "Row text: 23 | 17 | ABI3 | rs28394864 | 7.29e-05 | rs28394864 | 6.8e-06 | rs28394864 | 47450775 | A | G | 0.473 | 5.62 | 1.87e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.87e-08,
          "confidence": 0.7,
          "evidence": "Row text: 23 | 17 | ABI3 | rs28394864 | 7.29e-05 | rs28394864 | 6.8e-06 | rs28394864 | 47450775 | A | G | 0.473 | 5.62 | 1.87e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 5.62,
          "confidence": 0.65,
          "evidence": "Row text: 23 | 17 | ABI3 | rs28394864 | 7.29e-05 | rs28394864 | 6.8e-06 | rs28394864 | 47450775 | A | G | 0.473 | 5.62 | 1.87e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 23 | 17 | ABI3 | rs28394864 | 7.29e-05 | rs28394864 | 6.8e-06 | rs28394864 | 47450775 | A | G | 0.473 | 5.62 | 1.87e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00070",
      "fields": [
        {
          "field": "Name",
          "value": "rs2632516",
          "confidence": 0.9,
          "evidence": "Row text: -- | 17 | BZRAP1-AS1 | rs2632516 | 1.42e-09 | rs2632516 | 0.005 | rs2632516 | 56409089 | C | G | 0.455 | −4.90 | 9.66e-07 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.42e-09,
          "confidence": 0.7,
          "evidence": "Row text: -- | 17 | BZRAP1-AS1 | rs2632516 | 1.42e-09 | rs2632516 | 0.005 | rs2632516 | 56409089 | C | G | 0.455 | −4.90 | 9.66e-07 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: -- | 17 | BZRAP1-AS1 | rs2632516 | 1.42e-09 | rs2632516 | 0.005 | rs2632516 | 56409089 | C | G | 0.455 | −4.90 | 9.66e-07 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: -- | 17 | BZRAP1-AS1 | rs2632516 | 1.42e-09 | rs2632516 | 0.005 | rs2632516 | 56409089 | C | G | 0.455 | −4.90 | 9.66e-07 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00071",
      "fields": [
        {
          "field": "Name",
          "value": "rs2632516",
          "confidence": 0.9,
          "evidence": "Row text: -- | 17 | BZRAP1-AS1 | rs2632516 | 1.42e-09 | rs2632516 | 0.005 | rs2632516 | 56409089 | C | G | 0.455 | −4.90 | 9.66e-07 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 0.005,
          "confidence": 0.7,
          "evidence": "Row text: -- | 17 | BZRAP1-AS1 | rs2632516 | 1.42e-09 | rs2632516 | 0.005 | rs2632516 | 56409089 | C | G | 0.455 | −4.90 | 9.66e-07 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: -- | 17 | BZRAP1-AS1 | rs2632516 | 1.42e-09 | rs2632516 | 0.005 | rs2632516 | 56409089 | C | G | 0.455 | −4.90 | 9.66e-07 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: -- | 17 | BZRAP1-AS1 | rs2632516 | 1.42e-09 | rs2632516 | 0.005 | rs2632516 | 56409089 | C | G | 0.455 | −4.90 | 9.66e-07 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00072",
      "fields": [
        {
          "field": "Name",
          "value": "rs2632516",
          "confidence": 0.9,
          "evidence": "Row text: -- | 17 | BZRAP1-AS1 | rs2632516 | 1.42e-09 | rs2632516 | 0.005 | rs2632516 | 56409089 | C | G | 0.455 | −4.90 | 9.66e-07 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 9.66e-07,
          "confidence": 0.7,
          "evidence": "Row text: -- | 17 | BZRAP1-AS1 | rs2632516 | 1.42e-09 | rs2632516 | 0.005 | rs2632516 | 56409089 | C | G | 0.455 | −4.90 | 9.66e-07 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": -4.9,
          "confidence": 0.65,
          "evidence": "Row text: -- | 17 | BZRAP1-AS1 | rs2632516 | 1.42e-09 | rs2632516 | 0.005 | rs2632516 | 56409089 | C | G | 0.455 | −4.90 | 9.66e-07 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: -- | 17 | BZRAP1-AS1 | rs2632516 | 1.42e-09 | rs2632516 | 0.005 | rs2632516 | 56409089 | C | G | 0.455 | −4.90 | 9.66e-07 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"L",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00073",
      "fields": [
        {
          "field": "Name",
          "value": "rs8093731",
          "confidence": 0.9,
          "evidence": "Row text: -- | 18 | SUZ12P1 | rs8093731 | 4.63e-08 | rs8093731 | 0.766 | rs8093731 | 29088958 | T | C | 0.01 | −2.17 | 0.03 | ?-?-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 4.63e-08,
          "confidence": 0.7,
          "evidence": "Row text: -- | 18 | SUZ12P1 | rs8093731 | 4.63e-08 | rs8093731 | 0.766 | rs8093731 | 29088958 | T | C | 0.01 | −2.17 | 0.03 | ?-?-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: -- | 18 | SUZ12P1 | rs8093731 | 4.63e-08 | rs8093731 | 0.766 | rs8093731 | 29088958 | T | C | 0.01 | −2.17 | 0.03 | ?-?-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: -- | 18 | SUZ12P1 | rs8093731 | 4.63e-08 | rs8093731 | 0.766 | rs8093731 | 29088958 | T | C | 0.01 | −2.17 | 0.03 | ?-?-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00074",
      "fields": [
        {
          "field": "Name",
          "value": "rs8093731",
          "confidence": 0.9,
          "evidence": "Row text: -- | 18 | SUZ12P1 | rs8093731 | 4.63e-08 | rs8093731 | 0.766 | rs8093731 | 29088958 | T | C | 0.01 | −2.17 | 0.03 | ?-?-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 0.766,
          "confidence": 0.7,
          "evidence": "Row text: -- | 18 | SUZ12P1 | rs8093731 | 4.63e-08 | rs8093731 | 0.766 | rs8093731 | 29088958 | T | C | 0.01 | −2.17 | 0.03 | ?-?-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: -- | 18 | SUZ12P1 | rs8093731 | 4.63e-08 | rs8093731 | 0.766 | rs8093731 | 29088958 | T | C | 0.01 | −2.17 | 0.03 | ?-?-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: -- | 18 | SUZ12P1 | rs8093731 | 4.63e-08 | rs8093731 | 0.766 | rs8093731 | 29088958 | T | C | 0.01 | −2.17 | 0.03 | ?-?-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00075",
      "fields": [
        {
          "field": "Name",
          "value": "rs8093731",
          "confidence": 0.9,
          "evidence": "Row text: -- | 18 | SUZ12P1 | rs8093731 | 4.63e-08 | rs8093731 | 0.766 | rs8093731 | 29088958 | T | C | 0.01 | −2.17 | 0.03 | ?-?-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 0.03,
          "confidence": 0.7,
          "evidence": "Row text: -- | 18 | SUZ12P1 | rs8093731 | 4.63e-08 | rs8093731 | 0.766 | rs8093731 | 29088958 | T | C | 0.01 | −2.17 | 0.03 | ?-?-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": -2.17,
          "confidence": 0.65,
          "evidence": "Row text: -- | 18 | SUZ12P1 | rs8093731 | 4.63e-08 | rs8093731 | 0.766 | rs8093731 | 29088958 | T | C | 0.01 | −2.17 | 0.03 | ?-?-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: -- | 18 | SUZ12P1 | rs8093731 | 4.63e-08 | rs8093731 | 0.766 | rs8093731 | 29088958 | T | C | 0.01 | −2.17 | 0.03 | ?-?-\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus\"}, ",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00076",
      "fields": [
        {
          "field": "Name",
          "value": "rs76726049",
          "confidence": 0.9,
          "evidence": "Row text: 24 | 18 | ALPK2 | rs76726049 | 0.039 | rs76726049 | 1.83e-07 | rs76726049 | 56189459 | C | T | 0.014 | 5.52 | 3.3e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 0.039,
          "confidence": 0.7,
          "evidence": "Row text: 24 | 18 | ALPK2 | rs76726049 | 0.039 | rs76726049 | 1.83e-07 | rs76726049 | 56189459 | C | T | 0.014 | 5.52 | 3.3e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 24 | 18 | ALPK2 | rs76726049 | 0.039 | rs76726049 | 1.83e-07 | rs76726049 | 56189459 | C | T | 0.014 | 5.52 | 3.3e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 24 | 18 | ALPK2 | rs76726049 | 0.039 | rs76726049 | 1.83e-07 | rs76726049 | 56189459 | C | T | 0.014 | 5.52 | 3.3e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00077",
      "fields": [
        {
          "field": "Name",
          "value": "rs76726049",
          "confidence": 0.9,
          "evidence": "Row text: 24 | 18 | ALPK2 | rs76726049 | 0.039 | rs76726049 | 1.83e-07 | rs76726049 | 56189459 | C | T | 0.014 | 5.52 | 3.3e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.83e-07,
          "confidence": 0.7,
          "evidence": "Row text: 24 | 18 | ALPK2 | rs76726049 | 0.039 | rs76726049 | 1.83e-07 | rs76726049 | 56189459 | C | T | 0.014 | 5.52 | 3.3e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 24 | 18 | ALPK2 | rs76726049 | 0.039 | rs76726049 | 1.83e-07 | rs76726049 | 56189459 | C | T | 0.014 | 5.52 | 3.3e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 24 | 18 | ALPK2 | rs76726049 | 0.039 | rs76726049 | 1.83e-07 | rs76726049 | 56189459 | C | T | 0.014 | 5.52 | 3.3e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00078",
      "fields": [
        {
          "field": "Name",
          "value": "rs76726049",
          "confidence": 0.9,
          "evidence": "Row text: 24 | 18 | ALPK2 | rs76726049 | 0.039 | rs76726049 | 1.83e-07 | rs76726049 | 56189459 | C | T | 0.014 | 5.52 | 3.3e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 3.3e-08,
          "confidence": 0.7,
          "evidence": "Row text: 24 | 18 | ALPK2 | rs76726049 | 0.039 | rs76726049 | 1.83e-07 | rs76726049 | 56189459 | C | T | 0.014 | 5.52 | 3.3e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 5.52,
          "confidence": 0.65,
          "evidence": "Row text: 24 | 18 | ALPK2 | rs76726049 | 0.039 | rs76726049 | 1.83e-07 | rs76726049 | 56189459 | C | T | 0.014 | 5.52 | 3.3e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 24 | 18 | ALPK2 | rs76726049 | 0.039 | rs76726049 | 1.83e-07 | rs76726049 | 56189459 | C | T | 0.014 | 5.52 | 3.3e-08 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00079",
      "fields": [
        {
          "field": "Name",
          "value": "rs4147929",
          "confidence": 0.9,
          "evidence": "Row text: 25 | 19 | ABCA7 | rs4147929 | 8.64e-09 | rs3752241 | 2.87e-08 | rs111278892 | 1039323 | G | C | 0.161 | 6.50 | 7.93e-11 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 8.64e-09,
          "confidence": 0.7,
          "evidence": "Row text: 25 | 19 | ABCA7 | rs4147929 | 8.64e-09 | rs3752241 | 2.87e-08 | rs111278892 | 1039323 | G | C | 0.161 | 6.50 | 7.93e-11 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 25 | 19 | ABCA7 | rs4147929 | 8.64e-09 | rs3752241 | 2.87e-08 | rs111278892 | 1039323 | G | C | 0.161 | 6.50 | 7.93e-11 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 25 | 19 | ABCA7 | rs4147929 | 8.64e-09 | rs3752241 | 2.87e-08 | rs111278892 | 1039323 | G | C | 0.161 | 6.50 | 7.93e-11 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00080",
      "fields": [
        {
          "field": "Name",
          "value": "rs3752241",
          "confidence": 0.9,
          "evidence": "Row text: 25 | 19 | ABCA7 | rs4147929 | 8.64e-09 | rs3752241 | 2.87e-08 | rs111278892 | 1039323 | G | C | 0.161 | 6.50 | 7.93e-11 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.87e-08,
          "confidence": 0.7,
          "evidence": "Row text: 25 | 19 | ABCA7 | rs4147929 | 8.64e-09 | rs3752241 | 2.87e-08 | rs111278892 | 1039323 | G | C | 0.161 | 6.50 | 7.93e-11 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 25 | 19 | ABCA7 | rs4147929 | 8.64e-09 | rs3752241 | 2.87e-08 | rs111278892 | 1039323 | G | C | 0.161 | 6.50 | 7.93e-11 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 25 | 19 | ABCA7 | rs4147929 | 8.64e-09 | rs3752241 | 2.87e-08 | rs111278892 | 1039323 | G | C | 0.161 | 6.50 | 7.93e-11 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00081",
      "fields": [
        {
          "field": "Name",
          "value": "rs111278892",
          "confidence": 0.9,
          "evidence": "Row text: 25 | 19 | ABCA7 | rs4147929 | 8.64e-09 | rs3752241 | 2.87e-08 | rs111278892 | 1039323 | G | C | 0.161 | 6.50 | 7.93e-11 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 7.93e-11,
          "confidence": 0.7,
          "evidence": "Row text: 25 | 19 | ABCA7 | rs4147929 | 8.64e-09 | rs3752241 | 2.87e-08 | rs111278892 | 1039323 | G | C | 0.161 | 6.50 | 7.93e-11 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 6.5,
          "confidence": 0.65,
          "evidence": "Row text: 25 | 19 | ABCA7 | rs4147929 | 8.64e-09 | rs3752241 | 2.87e-08 | rs111278892 | 1039323 | G | C | 0.161 | 6.50 | 7.93e-11 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 25 | 19 | ABCA7 | rs4147929 | 8.64e-09 | rs3752241 | 2.87e-08 | rs111278892 | 1039323 | G | C | 0.161 | 6.50 | 7.93e-11 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00082",
      "fields": [
        {
          "field": "Name",
          "value": "rs41289512",
          "confidence": 0.9,
          "evidence": "Row text: 26 | 19 | APOE | rs41289512 | 2.7e-194 | rs75627662 | 9.51e-296 | rs41289512 | 45351516 | G | C | 0.039 | 35.50 | 5.790000000000001e-276 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 2.7e-194,
          "confidence": 0.7,
          "evidence": "Row text: 26 | 19 | APOE | rs41289512 | 2.7e-194 | rs75627662 | 9.51e-296 | rs41289512 | 45351516 | G | C | 0.039 | 35.50 | 5.790000000000001e-276 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 26 | 19 | APOE | rs41289512 | 2.7e-194 | rs75627662 | 9.51e-296 | rs41289512 | 45351516 | G | C | 0.039 | 35.50 | 5.790000000000001e-276 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 26 | 19 | APOE | rs41289512 | 2.7e-194 | rs75627662 | 9.51e-296 | rs41289512 | 45351516 | G | C | 0.039 | 35.50 | 5.790000000000001e-276 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00083",
      "fields": [
        {
          "field": "Name",
          "value": "rs75627662",
          "confidence": 0.9,
          "evidence": "Row text: 26 | 19 | APOE | rs41289512 | 2.7e-194 | rs75627662 | 9.51e-296 | rs41289512 | 45351516 | G | C | 0.039 | 35.50 | 5.790000000000001e-276 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 9.51e-296,
          "confidence": 0.7,
          "evidence": "Row text: 26 | 19 | APOE | rs41289512 | 2.7e-194 | rs75627662 | 9.51e-296 | rs41289512 | 45351516 | G | C | 0.039 | 35.50 | 5.790000000000001e-276 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 26 | 19 | APOE | rs41289512 | 2.7e-194 | rs75627662 | 9.51e-296 | rs41289512 | 45351516 | G | C | 0.039 | 35.50 | 5.790000000000001e-276 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 26 | 19 | APOE | rs41289512 | 2.7e-194 | rs75627662 | 9.51e-296 | rs41289512 | 45351516 | G | C | 0.039 | 35.50 | 5.790000000000001e-276 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00084",
      "fields": [
        {
          "field": "Name",
          "value": "rs41289512",
          "confidence": 0.9,
          "evidence": "Row text: 26 | 19 | APOE | rs41289512 | 2.7e-194 | rs75627662 | 9.51e-296 | rs41289512 | 45351516 | G | C | 0.039 | 35.50 | 5.790000000000001e-276 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 5.790000000000001e-276,
          "confidence": 0.7,
          "evidence": "Row text: 26 | 19 | APOE | rs41289512 | 2.7e-194 | rs75627662 | 9.51e-296 | rs41289512 | 45351516 | G | C | 0.039 | 35.50 | 5.790000000000001e-276 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 35.5,
          "confidence": 0.65,
          "evidence": "Row text: 26 | 19 | APOE | rs41289512 | 2.7e-194 | rs75627662 | 9.51e-296 | rs41289512 | 45351516 | G | C | 0.039 | 35.50 | 5.790000000000001e-276 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 26 | 19 | APOE | rs41289512 | 2.7e-194 | rs75627662 | 9.51e-296 | rs41289512 | 45351516 | G | C | 0.039 | 35.50 | 5.790000000000001e-276 | ?+++\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00085",
      "fields": [
        {
          "field": "Name",
          "value": "rs76320948",
          "confidence": 0.9,
          "evidence": "Row text: 27 | 19 | AC074212.3 | rs76320948 | 1.54e-05 | rs76320948 | 1.8e-05 | rs76320948 | 46241841 | T | C | 0.046 | 5.46 | 4.64e-08 | ?+?+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.54e-05,
          "confidence": 0.7,
          "evidence": "Row text: 27 | 19 | AC074212.3 | rs76320948 | 1.54e-05 | rs76320948 | 1.8e-05 | rs76320948 | 46241841 | T | C | 0.046 | 5.46 | 4.64e-08 | ?+?+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 27 | 19 | AC074212.3 | rs76320948 | 1.54e-05 | rs76320948 | 1.8e-05 | rs76320948 | 46241841 | T | C | 0.046 | 5.46 | 4.64e-08 | ?+?+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 27 | 19 | AC074212.3 | rs76320948 | 1.54e-05 | rs76320948 | 1.8e-05 | rs76320948 | 46241841 | T | C | 0.046 | 5.46 | 4.64e-08 | ?+?+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00086",
      "fields": [
        {
          "field": "Name",
          "value": "rs76320948",
          "confidence": 0.9,
          "evidence": "Row text: 27 | 19 | AC074212.3 | rs76320948 | 1.54e-05 | rs76320948 | 1.8e-05 | rs76320948 | 46241841 | T | C | 0.046 | 5.46 | 4.64e-08 | ?+?+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.8e-05,
          "confidence": 0.7,
          "evidence": "Row text: 27 | 19 | AC074212.3 | rs76320948 | 1.54e-05 | rs76320948 | 1.8e-05 | rs76320948 | 46241841 | T | C | 0.046 | 5.46 | 4.64e-08 | ?+?+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 27 | 19 | AC074212.3 | rs76320948 | 1.54e-05 | rs76320948 | 1.8e-05 | rs76320948 | 46241841 | T | C | 0.046 | 5.46 | 4.64e-08 | ?+?+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 27 | 19 | AC074212.3 | rs76320948 | 1.54e-05 | rs76320948 | 1.8e-05 | rs76320948 | 46241841 | T | C | 0.046 | 5.46 | 4.64e-08 | ?+?+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00087",
      "fields": [
        {
          "field": "Name",
          "value": "rs76320948",
          "confidence": 0.9,
          "evidence": "Row text: 27 | 19 | AC074212.3 | rs76320948 | 1.54e-05 | rs76320948 | 1.8e-05 | rs76320948 | 46241841 | T | C | 0.046 | 5.46 | 4.64e-08 | ?+?+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 4.64e-08,
          "confidence": 0.7,
          "evidence": "Row text: 27 | 19 | AC074212.3 | rs76320948 | 1.54e-05 | rs76320948 | 1.8e-05 | rs76320948 | 46241841 | T | C | 0.046 | 5.46 | 4.64e-08 | ?+?+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 5.46,
          "confidence": 0.65,
          "evidence": "Row text: 27 | 19 | AC074212.3 | rs76320948 | 1.54e-05 | rs76320948 | 1.8e-05 | rs76320948 | 46241841 | T | C | 0.046 | 5.46 | 4.64e-08 | ?+?+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 27 | 19 | AC074212.3 | rs76320948 | 1.54e-05 | rs76320948 | 1.8e-05 | rs76320948 | 46241841 | T | C | 0.046 | 5.46 | 4.64e-08 | ?+?+\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00088",
      "fields": [
        {
          "field": "Name",
          "value": "rs3865444",
          "confidence": 0.9,
          "evidence": "Row text: 28 | 19 | CD33 | rs3865444 | 4.25e-08 | rs3865444 | 4.97e-05 | rs3865444 | 51727962 | A | C | 0.32 | −5.81 | 6.34e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 4.25e-08,
          "confidence": 0.7,
          "evidence": "Row text: 28 | 19 | CD33 | rs3865444 | 4.25e-08 | rs3865444 | 4.97e-05 | rs3865444 | 51727962 | A | C | 0.32 | −5.81 | 6.34e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 28 | 19 | CD33 | rs3865444 | 4.25e-08 | rs3865444 | 4.97e-05 | rs3865444 | 51727962 | A | C | 0.32 | −5.81 | 6.34e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 28 | 19 | CD33 | rs3865444 | 4.25e-08 | rs3865444 | 4.97e-05 | rs3865444 | 51727962 | A | C | 0.32 | −5.81 | 6.34e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00089",
      "fields": [
        {
          "field": "Name",
          "value": "rs3865444",
          "confidence": 0.9,
          "evidence": "Row text: 28 | 19 | CD33 | rs3865444 | 4.25e-08 | rs3865444 | 4.97e-05 | rs3865444 | 51727962 | A | C | 0.32 | −5.81 | 6.34e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 4.97e-05,
          "confidence": 0.7,
          "evidence": "Row text: 28 | 19 | CD33 | rs3865444 | 4.25e-08 | rs3865444 | 4.97e-05 | rs3865444 | 51727962 | A | C | 0.32 | −5.81 | 6.34e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 28 | 19 | CD33 | rs3865444 | 4.25e-08 | rs3865444 | 4.97e-05 | rs3865444 | 51727962 | A | C | 0.32 | −5.81 | 6.34e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 28 | 19 | CD33 | rs3865444 | 4.25e-08 | rs3865444 | 4.97e-05 | rs3865444 | 51727962 | A | C | 0.32 | −5.81 | 6.34e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00090",
      "fields": [
        {
          "field": "Name",
          "value": "rs3865444",
          "confidence": 0.9,
          "evidence": "Row text: 28 | 19 | CD33 | rs3865444 | 4.25e-08 | rs3865444 | 4.97e-05 | rs3865444 | 51727962 | A | C | 0.32 | −5.81 | 6.34e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 6.34e-09,
          "confidence": 0.7,
          "evidence": "Row text: 28 | 19 | CD33 | rs3865444 | 4.25e-08 | rs3865444 | 4.97e-05 | rs3865444 | 51727962 | A | C | 0.32 | −5.81 | 6.34e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": -5.81,
          "confidence": 0.65,
          "evidence": "Row text: 28 | 19 | CD33 | rs3865444 | 4.25e-08 | rs3865444 | 4.97e-05 | rs3865444 | 51727962 | A | C | 0.32 | −5.81 | 6.34e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 28 | 19 | CD33 | rs3865444 | 4.25e-08 | rs3865444 | 4.97e-05 | rs3865444 | 51727962 | A | C | 0.32 | −5.81 | 6.34e-09 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Locus",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00091",
      "fields": [
        {
          "field": "Name",
          "value": "rs6014724",
          "confidence": 0.9,
          "evidence": "Row text: 29 | 20 | CASS4 | rs6014724 | 8.72e-08 | rs6014724 | 6.32e-06 | rs6014724 | 54998544 | G | A | 0.089 | −6.18 | 6.56e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 8.72e-08,
          "confidence": 0.7,
          "evidence": "Row text: 29 | 20 | CASS4 | rs6014724 | 8.72e-08 | rs6014724 | 6.32e-06 | rs6014724 | 54998544 | G | A | 0.089 | −6.18 | 6.56e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 29 | 20 | CASS4 | rs6014724 | 8.72e-08 | rs6014724 | 6.32e-06 | rs6014724 | 54998544 | G | A | 0.089 | −6.18 | 6.56e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 29 | 20 | CASS4 | rs6014724 | 8.72e-08 | rs6014724 | 6.32e-06 | rs6014724 | 54998544 | G | A | 0.089 | −6.18 | 6.56e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00092",
      "fields": [
        {
          "field": "Name",
          "value": "rs6014724",
          "confidence": 0.9,
          "evidence": "Row text: 29 | 20 | CASS4 | rs6014724 | 8.72e-08 | rs6014724 | 6.32e-06 | rs6014724 | 54998544 | G | A | 0.089 | −6.18 | 6.56e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 6.32e-06,
          "confidence": 0.7,
          "evidence": "Row text: 29 | 20 | CASS4 | rs6014724 | 8.72e-08 | rs6014724 | 6.32e-06 | rs6014724 | 54998544 | G | A | 0.089 | −6.18 | 6.56e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": "",
          "confidence": 0.65,
          "evidence": "Row text: 29 | 20 | CASS4 | rs6014724 | 8.72e-08 | rs6014724 | 6.32e-06 | rs6014724 | 54998544 | G | A | 0.089 | −6.18 | 6.56e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 29 | 20 | CASS4 | rs6014724 | 8.72e-08 | rs6014724 | 6.32e-06 | rs6014724 | 54998544 | G | A | 0.089 | −6.18 | 6.56e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30617256_table1_R00093",
      "fields": [
        {
          "field": "Name",
          "value": "rs6014724",
          "confidence": 0.9,
          "evidence": "Row text: 29 | 20 | CASS4 | rs6014724 | 8.72e-08 | rs6014724 | 6.32e-06 | rs6014724 | 54998544 | G | A | 0.089 | −6.18 | 6.56e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 6.56e-10,
          "confidence": 0.7,
          "evidence": "Row text: 29 | 20 | CASS4 | rs6014724 | 8.72e-08 | rs6014724 | 6.32e-06 | rs6014724 | 54998544 | G | A | 0.089 | −6.18 | 6.56e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": -6.18,
          "confidence": 0.65,
          "evidence": "Row text: 29 | 20 | CASS4 | rs6014724 | 8.72e-08 | rs6014724 | 6.32e-06 | rs6014724 | 54998544 | G | A | 0.089 | −6.18 | 6.56e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "Genome-wide meta-analysis for AD status Phase 1 involved a genome-wide meta-analysis for clinically-diagnosed AD case-control status using cohorts collected by 3 independent consortia (Alzheimer’s disease working group of the Psychiatric Genomic",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "ntary Note and the Life Sciences Reporting Summary. Data Analysis Single-marker association analysis—Genome-wide association analysis (GWAS) for each of the ADSP, PGC-ALZ and UKB datasets was performed in PLINK47, using logistic regression for dichotomous phen",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "1000G",
          "confidence": 0.85,
          "evidence": "lication of the lead SNP or an LD-proxy of the lead SNP (r2>0.9) in each locus. We were unable to test two loci as the lead SNPs (and SNPs in high LD) either were not present in the Icelandic reference panel or were not imputed with sufficient quality. For 6 o",
          "rule": "panel keyword detection (TOPMed/HRC/1000G)",
          "needs_review": false
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": "iatric Genomics Consortium (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "72500",
          "confidence": 0.7,
          "evidence": " (PGC-ALZ), the International Genomics of Alzheimer’s Project (IGAP), and the Alzheimer’s Disease Sequencing Project (ADSP)), totalling 79,145 individuals (N effective sample size N =72,500) of European ancestry sum; eff and 9,862,738 genetic variants passing ",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "ADSP",
          "confidence": 0.8,
          "evidence": "Row text: 29 | 20 | CASS4 | rs6014724 | 8.72e-08 | rs6014724 | 6.32e-06 | rs6014724 | 54998544 | G | A | 0.089 | −6.18 | 6.56e-10 | ?---\n[column_mapping] {\"Region | Locus\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.1695, \"needs_review\": true, \"match_hint\": \"Loc",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    }
  ]
}